炎症指标MLR在冠心病的研究进展

Research Progress of Inflammatory Marker MLR in Coronary Heart Disease

摘要: 冠状动脉粥样硬化疾病是全球重大疾病基本之一，所以预防作用很关键，其中炎症作用在冠心病的发生、发展中其扮演者中不可替代的重要作用这已经是近年来广泛学者所公认的事实。单核细胞与淋巴细胞比值(MLR)作为简便而容易获取的新型炎症标志物，它不仅与冠心病的发病机制存在关系，而且与冠状动脉侧支循环形成不良、冠状动脉狭窄程度、支架内再狭窄等方面有关，本文将MLR与冠心病的研究现状做出综述。

Abstract: Coronary atherosclerotic disease is one of the most important diseases in the world, so the key of prevention is inflammation, which plays an irreplaceable role in the occurrence and development of coronary heart disease, which has been widely recognized by scholars in recent years. The ratio of monocyte to lymphocyte (MLR) is a simple and easy to obtain new inflammatory marker. It is not only related to the pathogenesis of coronary heart disease, but also related to the formation of cor-onary collateral circulation, the degree of coronary artery stenosis, in stent restenosis and so on. This article reviews the research status of MLR and coronary heart disease.